Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-003823
Filing Date
2025-04-11
Accepted
2025-04-11 16:15:19
Documents
1
Period of Report
2025-04-10

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8374
  Complete submission text file 0001641172-25-003823.txt   9922
Mailing Address PFIZER INC. ATTN CORPORATE SECRETARY 235 RAST 42ND STREET NEW YORK NY 10017
Business Address
MADDALUNA ANTHONY J (Reporting) CIK: 0001566333 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40652 | Film No.: 25832258

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Issuer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)